# Replimune Group (REPL) — Analyst Forecast

REPL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/repl/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 0 | 0 | 8 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $17.00 | $19.00 | $21.00 | 3 |

Last price $11.75 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 26, 2026 | JP Morgan | Maintained | Overweight | $21.00 |
| Aug 7, 2026 | Wedbush | Upgraded | Neutral → Outperform | $19.00 |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | $20.00 |
| Aug 4, 2026 | Leerink Partners | Upgraded | Market Perform → Outperform | $17.00 |
| Jul 31, 2026 | Cantor Fitzgerald | Upgraded | Neutral → Overweight | — |
| Jul 31, 2026 | Wedbush | Maintained | Neutral | $12.00 |
| Jun 30, 2026 | Wedbush | Maintained | Neutral | $9.00 |
| Jun 1, 2026 | Wedbush | Maintained | Neutral | $6.00 |
| Apr 13, 2026 | HC Wainwright & Co. | Downgraded | Buy → Sell | — |
| Apr 13, 2026 | Jefferies | Downgraded | Buy → Hold | $2.00 |
| Apr 13, 2026 | Wedbush | Downgraded | Outperform → Neutral | $2.00 |
| Apr 13, 2026 | JP Morgan | Downgraded | Neutral → Underweight | — |
| Apr 13, 2026 | Leerink Partners | Downgraded | Outperform → Market Perform | $2.00 |
| Apr 13, 2026 | Cantor Fitzgerald | Downgraded | Overweight → Neutral | — |
| Feb 5, 2026 | Piper Sandler | Maintained | Overweight | $14.00 |
| Feb 4, 2026 | Wedbush | Maintained | Outperform | $19.00 |
| Nov 3, 2025 | BMO Capital | Upgraded | Underperform → Market Perform | $11.00 |
| Oct 27, 2025 | HC Wainwright & Co. | Upgraded | Neutral → Buy | $12.00 |
| Oct 20, 2025 | Wedbush | Upgraded | Neutral → Outperform | $18.00 |
| Oct 20, 2025 | Leerink Partners | Upgraded | Market Perform → Outperform | $13.00 |

## Frequently Asked Questions

### What is the price target for REPL stock?

The average 12-month analyst price target for Replimune Group (REPL) is $19.00, with a high estimate of $21.00 and a low of $17.00, across 3 analysts.

### Is REPL a buy, sell, or hold?

Analysts covering Replimune Group currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for REPL?

The average price target of $19.00 implies 61.70% upside from the last price of $11.75.

### What is the latest analyst rating on REPL?

On Aug 26, 2026, JP Morgan maintained Replimune Group at Overweight with a price target of $21.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).